Lexicon Pharmaceuticals Inc. (LXRX) News Headlines

▮ More

Date

Headline

12/20/2019 7:07:28 AM Lexicon Pharma Topline Phase 3 Data For Sotagliflozin In Type 2 Diabetes Meets End Points

12/5/2019 7:14:16 AM Lexicon Announces Positive Topline Data From Phase 1 Study Of LX9211

12/3/2019 1:25:09 AM AGTC Awaits Data In Jan., EVFM Walks The Talk, Today's A Big Day For ALDX

12/2/2019 7:21:58 AM Lexicon Pharma Gets Formal Dispute Resolution Request Decision From FDA’s Office Of New Drugs For Sotagliflozin

9/18/2019 10:38:56 PM 5 Top Gainers In Healthcare Sector (LXRX, ECOR, ARAV…)

9/16/2019 10:26:27 PM 7 Top Gainers In Healthcare Sector (KOD, LXRX, WVE...)

9/14/2019 2:18:37 PM Week Ahead In Pharmaceuticals: 7 Stocks To Watch (AIMT, LXRX, TXG…)

9/10/2019 4:06:28 PM Lexicon Pharmaceuticals Announces Termination Of Alliance And Settlement With Sanofi

8/5/2019 9:46:46 PM 5 Top Gainers In Healthcare Sector (ALLK, IMGN, LXRX...)

8/1/2019 10:10:16 AM Wedbush Reiterates Lexicon Pharmaceuticals Inc. (LXRX) At Outperform With $17 Down From $35 Price Target

8/1/2019 12:02:07 AM 5 Top Losers In Healthcare Sector (TTOO, LXRX, ACRS…)

7/29/2019 11:49:07 PM 6 Top Losers In Healthcare Sector (LXRX, XBIO, ONCY...)

7/27/2019 11:35:08 AM Sanofi Terminates Partnership With Lexicon To Develop Diabetes Drug

6/11/2019 12:57:20 PM Wedbush Reiterates Lexicon Pharmaceuticals Inc. (LXRX) At Outperform With $35 Price Target

5/2/2019 8:56:18 AM Wedbush Is Lowering Lexicon Pharmaceuticals Inc. (LXRX) FY20 Rev. Estimate To 98.2 M From 98.3 M

5/2/2019 8:56:06 AM Wedbush Is Lowering Lexicon Pharmaceuticals Inc. (LXRX) FY19 Rev. Estimate To 63.8 M From 71.0 M

5/2/2019 8:55:49 AM Wedbush Is Increasing Lexicon Pharmaceuticals Inc. (LXRX) Q4 19 Rev. Estimate To 19.5 M From 19.3 M

5/2/2019 8:55:18 AM Wedbush Is Raising Lexicon Pharmaceuticals Inc. (LXRX) FY20 Estimate To -1.23 From -1.60

5/2/2019 8:55:04 AM Wedbush Is Raising Lexicon Pharmaceuticals Inc. (LXRX) Q4 20 Estimate To -0.27 From -0.36

5/2/2019 8:54:50 AM Wedbush Is Increasing Lexicon Pharmaceuticals Inc. (LXRX) Q3 20 Estimate To -0.30 From -0.39